Article

FDA News Digest, 10 December 2001

Author(s):

BioPharm International Editors

Approvals, warnings, hazards, and sentencing

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | Image Credit: © mylisa - © mylisa - stock.adobe.com
August 29th 2025

FDA Approves Moderna’s Updated COVID-19 Vaccines Targeting LP.8.1 Variant

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 29th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Blood sample tube contain with stem cell | Image Credit: © jarun011 - © jarun011 - stock.adobe.com
August 29th 2025

Zemcelpro Stem Cell Therapy Granted EC Conditional Marketing Authorizaion

Feliza Mirasol
Mastering Antibody-Drug Conjugates
August 29th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Scientist wearing blue gloves pointing at charts and graphs on a paper document while analyzing medical research data using a tablet in a laboratory setting, with a microscope and beakers nearby | Image Credit: ©crizzystudio – stock.adobe.com
August 29th 2025

Specification Equivalence: A Practical Approach to Method and Acceptance Criteria Equivalence

Gail Reed Joseph A. Albanese Yelena Ionova J. Mark Wiggins
Your Voice in Biopharma's Digital Shift: Manufacturing & Tech Adoption Survey
August 29th 2025

Your Voice in Biopharma's Digital Shift: Manufacturing & Tech Adoption Survey

Christopher Cole
© 2025 MJH Life Sciences

All rights reserved.